92 filings
Page 3 of 5
8-K
ao914qd5qt4y 59u
14 Nov 22
Icosavax Reports Third Quarter Financial Results and Provides
12:00am
EFFECT
pl50e5g2xrx cx2089
30 Aug 22
Notice of effectiveness
12:15am
CORRESP
6cuyiv
25 Aug 22
Correspondence with SEC
12:00am
UPLOAD
ejr8b2g3uvgme8
23 Aug 22
Letter from SEC
12:00am
S-3
x67yhpj
15 Aug 22
Shelf registration
6:34pm
8-K
6jefwny
15 Aug 22
Icosavax Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:40pm
8-K
ps34d0 y02oxi
28 Jun 22
Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV
4:10pm
8-K
ljq707ot5ghsytm 2mj
15 Jun 22
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
83yb d43u
16 May 22
Icosavax Reports First Quarter 2022 Financial Results and Provides Corporate Update
12:00am
DEFA14A
r9tbn8q4ubzbyy d3m
25 Apr 22
Additional proxy soliciting materials
4:56pm
DEF 14A
h01pvwz5nj1k1 pca72u
25 Apr 22
Definitive proxy
4:53pm
8-K
s4zi8huzh iy
25 Apr 22
Regulation FD Disclosure
8:01am
10-K
fb97y4 pgo99y
30 Mar 22
Annual report
5:03pm
8-K
zm8nqq6by2h koy
30 Mar 22
Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:39pm
8-K
sz8o9il4mt3 ywr5nt
25 Mar 22
Other Events
8:09am
8-K
ev8mjx
11 Feb 22
Departure of Directors or Certain Officers
5:20pm
8-K
2s6q5mvjrw5vrz7t ht4
7 Jan 22
Icosavax Provides Corporate Update and Anticipated
8:42am